Mubadala Bio and Lilly Announce Landmark Agreement to Advance Pharmaceutical Contract Manufacturing in Abu Dhabi

Eli Lilly and Company has entered into a strategic partnership with Mubadala Bio to enhance pharmaceutical contract manufacturing in Abu Dhabi. This collaboration will focus on localizing the packaging and logistics for Lilly's GLP-1 medicines. The agreement was announced at the Abu Dhabi Future Health Summit 2026 by Nabil Daoud, President and General Manager of the Intercontinental Hub at Eli Lilly.